• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans
  • .org
  • Districts
  • Media
  • SupportUs
  • Collaborate
  • Contact
  • Search
  • Join


Adverts help to support the work of this non-profit organisation. To go ad-free join as a Member.


Photo

BioTime Inc.

Started by caliban , Mar 25 2011 01:11 AM
economics regenerative medicine stemells tissue engineering regmed

  • Please log in to reply
777 replies to this topic

#181 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 23 May 2012 - 01:28 PM

BioTime and Subsidiary LifeMap Sciences, Inc. Announce Release of GeneCards ...
Virtual-Strategy Magazine - 8 hours ago
XenneX, a Division of LifeMap Sciences, Inc. and BioTime, Inc. (NYSE Amex:BTX), announced today the release of GeneCards®, Version 3.08, on May 20, 2012.

View the full article

#182 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 23 May 2012 - 07:27 PM

BioTime and Subsidiary LifeMap Sciences, Inc. Announce Agreement to Market ...
PharmaLive.com (press release) - 9 hours ago
ALAMEDA, Calif.--(BUSINESS WIRE)--May 22, 2012 - BioTime, Inc. (NYSE MKT: BTX) today announced that its subsidiary LifeMap Sciences, Inc. has entered into a license agreement with Yeda Research and Development Company Ltd, the technology transfer arm ...

View the full article

#183 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 01 June 2012 - 02:04 PM

Biotech Ideas That Will Change the World: Patrick Cox
InvestorIdeas.com (press release) - Jun 1, 2012
June 1, 2012 (InvestorIdeas.com Newswire) For Patrick Cox, disruptive technologies drive change and harbor opportunity. Cox, editor of Breakthrough Technology Alert and Technology Profits Confidential, and a contributor to The Daily Reckoning, ...

View the full article

sponsored ad

  • Advert

#184 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 31 May 2012 - 07:53 PM

Crawling through the tape to see what's working … not much!
Proactive Investors USA & Canada - May 31, 2012
The 6 W's: Who, what, where, when, why and what of it Mid-Day: The NASDAQ is DOWN -7.04 (-0.25%) to 2830.32 while the Dow is suprisingly UP +23.88 ...

View the full article

#185 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 30 May 2012 - 12:47 PM

BioTime CEO Dr. Michael West to Present at the Jefferies 2012 ...
MarketWatch (press release) - May 30, 2012
BioTime CEO Dr. Michael West to Present at the Jefferies 2012 Global Healthcare Conference. ALAMEDA, Calif., May 30, 2012 (BUSINESS WIRE) -- BioTime, ...
BIOTIME, INC. : BioTime CEO Dr. Michael West to Present at the ... - 4-traders

View the full article

#186 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 12 July 2012 - 06:40 PM

Happy with a flat sector versus downward spirals while, BioLife Solutions (OTC ...
Proactive Investors USA & Canada - Jul 12, 2012
The 6 W's: Who, what, where, when, why and what of it Mid-Day: The NASDAQ is DOWN -32.01 (-1.11%) to 2855.96 while the Dow is also DOWN -37.81 (-0.3%) to 12566.72.

View the full article

#187 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 18 July 2012 - 07:22 AM

BioTime Signs Agreements with Jade Therapeutics for Ophthalmological Drug ...
Business Wire (press release) - Jul 18, 2012
BioTime Signs Agreements with Jade Therapeutics for Ophthalmological Drug Delivery Applications of HyStem® Technology. ALAMEDA, Calif.

View the full article

#188 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 27 July 2012 - 01:18 AM

BioTime Subsidiary LifeMap Sciences, Inc. Announces Financing of Up to $3 ...
Business Wire (press release) - 2 hours ago
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) and its subsidiary LifeMap Sciences, Inc. (“LifeMap”) today announced that LifeMap entered into a Share Exchange and Contribution Agreement with Alfred D. Kingsley and a company ...

View the full article

#189 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 30 July 2012 - 01:02 PM

BioTime: Weak Pipeline Unlikely To Deliver
Seeking Alpha - 2 hours ago
Given BioTime's history of over-promising and under-delivering, as we detailed in a prior article, we felt it would be wise to take a deep look at BioTime's pipeline of products and research and see if it could justify the company's $210 million market ...

View the full article

#190 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 01 August 2012 - 12:45 PM

BioTime's Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.33 Million Grant ...
MarketWatch (press release) - 25 minutes ago
ALAMEDA, Calif. & JERUSALEM, Aug 01, 2012 (BUSINESS WIRE) -- BioTime, Inc. (nyse mkt:BTX) and its subsidiary Cell Cure Neurosciences Ltd.
BIOTIME, INC. : BioTime's Subsidiary Cell Cure Neurosciences Ltd. Awarded ... - 4-traders

View the full article

#191 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 02 August 2012 - 01:30 AM

BioTime's Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.33 Million Grant ...
Business Wire (press release) - 1 hour ago
ALAMEDA, Calif. & JERUSALEM--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) and its subsidiary Cell Cure Neurosciences Ltd. (Cell Cure) today announced that Cell Cure has been awarded a grant for 2012 of 5.04 million Shekels (approximately ...

View the full article

#192 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 01 August 2012 - 01:19 PM

BioTime Unit Cell Cure Gets Israel's Office Of The Chief Scientist Grant
NASDAQ - Aug 1, 2012
BioTime Unit Cell Cure Gets Israel's Office Of The Chief Scientist Grant. (RTTNews.com) - BioTime, Inc. (BTX) and its subsidiary Cell Cure Neurosciences Ltd.

View the full article

#193 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 09 August 2012 - 08:21 PM

BIOTIME, INC. : BioTime Announces Second Quarter 2012 Financial Results ...
4-traders - 27 minutes ago
BioTime, Inc. : BioTime Announces Second Quarter 2012 Financial Results and Recent Corporate Accomplishments. 08/09/2012 | 04:20pm US/Eastern.
BioTime Announces Second Quarter 2012 Financial Results And Recent ... - TheStreet.com (press release)

View the full article

#194 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 08 August 2012 - 06:25 PM

James Montier's Short Screen
NASDAQ - Aug 8, 2012
In May 2008 James Montier, fund manager at GMO, couldn't find opportunities to invest, he wrote an article about short selling: Joining The Dark Side: Pirates, Spies and Short Sellers.

View the full article

#195 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 10 August 2012 - 07:44 PM

BioTime, Inc. (AMEX: BTX) Q2/12 Results
Proactive Investors USA & Canada - 1 hour ago
Net loss was $5.5M or $0.11 per share. Net loss was $5.5M or $0.11 per share, compared to a net loss of $4.3M or $0.09 per share for Q2/11.

View the full article

#196 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 16 August 2012 - 12:51 PM

BIOTIME, INC. : BioTime and OncoCyte Corporation Publish Data on the Gene ...
4-traders - 58 minutes ago
BioTime, Inc. : BioTime and OncoCyte Corporation Publish Data on the Gene COL10A1 as a Marker and Potential Diagnostic for a Wide Array of Human Cancers.

View the full article

#197 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 16 August 2012 - 09:57 PM

Healthcare Business Report: Pfizer's Tofacitinib In Phase II, BioTime's ...
Wall St. Cheat Sheet - 2 hours ago
Pfizer's (NYSE:PFE) tofacitinib tablet eased symptoms such as pain and bleeding in patients suffering from ulcerative colitis, which is an inflammatory bowel disease, in a Phase II evaluation.

View the full article

#198 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 17 August 2012 - 06:36 AM

Big Gainers; Compucredit Holdings Corp. (CCRT), Geron Corporation (GERN)
SmallCap Network - 1 hour ago
CCRT launched a cash tender offer to buyback up to 8.2 million shares of its common stock for $10 per share, representing a premium of around 100% to the stock's closing price on Wednesday.

View the full article

#199 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 17 August 2012 - 04:33 PM

Marvell Tech's Q2 Earnings Fall 52% and 4 Hot Stocks to Notice
Wall St. Cheat Sheet - 2 hours ago
Ann Inc. (NYSE:ANN): Ann Inc.'s fiscal year 2012 gross margin rate performance is expected to be in the neighborhood of 55%, with their total selling general and administrative expenses expected to approach $1.140 billion.

View the full article

#200 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 18 August 2012 - 06:38 AM

Top Post-Market Nasdaq Movers (Geron, Harmonic, Vitesse, Exelixis, ZAGG ...
International Business Times - 2 hours ago
The top after-market Nasdaq gainers Friday were Geron Corporation, Harmonic Inc, Vitesse Semiconductor Corporation and Exelixis Inc. The top after-market Nasdaq losers were ZAGG Inc, Myriad Genetics, Questcor Pharmaceuticals Inc and Corinthian ...

View the full article

#201 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 16 August 2012 - 09:15 PM

IPL (LNT) Announces Proposed Settlement in Natural Gas Rate Case
StreetInsider.com (subscription) - Aug 16, 2012
Interstate Power and Light Company (IPL), a subsidiary of Alliant Energy Corporation (NYSE: LNT), the Iowa Office of Consumer Advocate (OCA) and the Iowa Consumers Coalition (ICC) filed today a unanimous settlement proposal with the Iowa Utilities ...

View the full article

#202 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 16 August 2012 - 07:37 PM

Earnings Report Card, Q2/12, Regenerative Medicine Universe
Proactive Investors USA & Canada - Aug 16, 2012
Report Card. An earnings release is a 'report card' of sorts for a public stem cell company. The current LPS (loss per share) standings reflect the universes' investing status; then add in their cash position for a better snapshot!

View the full article

#203 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 13 August 2012 - 11:14 AM

Galena Biopharma (GALE) Gets Japanese Patent for FBP Peptide Variants
StreetInsider.com (subscription) - Aug 13, 2012
Galena Biopharma, Inc. (Nasdaq: GALE), announced the issuance of a patent from the Japan Patent Office (JPO) for a Composition of Matter and Method of Treatment patent covering Folate Binding Protein (FBP) peptide variants for use either alone or in ...

View the full article

#204 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 17 August 2012 - 06:56 PM

Boehringer Ingelheim, Lilly (LLY) Receive FDA Approval for Tradjenta sNDA as ...
StreetInsider.com (subscription) - Aug 17, 2012
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for Tradjenta (linagliptin) tablets for use as ...

View the full article

#205 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 20 August 2012 - 12:09 PM

8 Intriguing Small Cap Biotechnology Companies For Your Consideration
Seeking Alpha - 11 minutes ago
Yahoo Finance lists 47 biotechnology companies valued between $100 million and $2 billion. Of these, eight gained more than 3% on Friday, most on no news at all.

View the full article

#206 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 20 August 2012 - 11:17 PM

Hot Option Plays: Bulls And Bears Chopping Around
Daily Markets - 32 minutes ago
Cusick's Corner 08-20-2012. The market thinks it is on vacation, chopping around breakeven for another session. One market where the action has not been positive, other than Bonds, has been Copper, JJC.

View the full article

#207 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 20 August 2012 - 03:09 PM

6 Biotech Stocks That Could Be In For A Short Squeeze
Seeking Alpha - 18 hours ago
Small cap biotechnology stocks are usually speculative situations where good news can cause the stocks to soar quickly. The sobering yin to that intoxicating yang is that bad news can mean the stocks plummet.

View the full article

#208 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 21 August 2012 - 08:38 PM

Healthcare Review: Invacare, Pluristem & Geron Jump, ImmunoCellular ...
Pharmaceutical Processing - 11 minutes ago
Share. Loading... U.S. stocks pared its early gain with the S&P 500 index retreating from a four-year high that came on optimism that Europe would take steps to contain its debt crisis.
Healthcare Review : Invacare, Intermune & Geron Jump while ImmunoCellular ... - Proactive Investors USA & Canada

View the full article

#209 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 21 August 2012 - 04:31 AM

4 Cash-Heavy Biotech Stocks That Analysts Rate As Strong Buy
Seeking Alpha - 18 hours ago
For some people having extra cash on hand brings a certain amount of comfort and security. For others, it seems like the cash is burning a hole in their pocket and they are eager to spend.

View the full article

#210 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 27 August 2012 - 12:54 PM

BIOTIME, INC. : BioTime Obtains Expanded License to HyStem® Technology
4-traders - 2 hours ago
BioTime, Inc. : BioTime Obtains Expanded License to HyStem® Technology. 08/27/2012 | 08:50am US/Eastern. - BioTime now holds exclusive worldwide license for all human medical applications of the core HyStem® technology -. BioTime, Inc. (NYSE MKT: ...
BioTime amends license agreement with University of Utah for HyStem technology - News-Medical.net
BioTime (BTX) Expands Licensing on HyStem-Ccvered Products - StreetInsider.com (subscription)

View the full article
Back to Ventures & Markets



Also tagged with one or more of these keywords: economics, regenerative medicine, stemells, tissue engineering, regmed

3 user(s) are reading this topic

0 members, 3 guests, 0 anonymous users

  1. LONGECITY
  2. → Round Table Discussion
  3. → Business
  4. → Ventures & Markets
  5. site rules